EFTA01493225.pdf

FINANCIAL TRUST COMPANY INC ACCT. W23560001 For the Period 7/1112 to 7/31/12 Note P indicates position adjusted for Pending Trade Activity. Unrealized Gainr Loss is shown as "N A" in cases where we do not have appropriate cost information for all lax lots comprising the position. Please contact your J P Morgan team for additional information. Equity Detail Adjusted Tax Cost Unrealized Est. Annual Inc. Price Quantity Value Original Cost Gain/Loss Accrued Div. Yield US Large Cap Equity ARIAD PHARMACEUTICALS INC 19.13 16,535.000 316,314.55 251,475.52 64,839.03 04033A-10-0 ARIA BIOGEN IDEC INC 145.83 2.095 000 305,513.85 250,454.95 55,058.90 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 64.77 1.000.000 000 647,660.00 1,000,000.00 (352,340.00) 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07)15,'11 MS 21 09 2515A1-A7-6 FACEBOOK INC-A 21.71 35,000.000 759,850.00 1,330,000.00 (570,150.00) 30303M-10-2 FE( GS CONT BUFF EQ SPX 7/9/13 101.74 3,000,000.000 3,052,140.00 3,000,000.00 52,140.00 80% CONTIN BARRIER- 10.5%CPN 15% CAP INITIAL LEVEL-6/2M 2 SPX:1355.69 38143U-Z9-5 HSBC MARKET PLUS SPX 06117/13 100.71 5,000,000.000 5,035,500.00 5,000,000.00 36,500.00 72% KO BARRIER- 0%CPN ,UNCAPPED INITIAL LEVEL-02/14112 SPX:1350.50 4042K1-X0-1 JP Morgan Account W23560001 Page 5 of 28 Consolidated Statement Page 8 Confidential Treatment Requested by JPMorgan JPM-SDNY-000 16066 Chase CONFIDENTIAL SDNY_GM_00285264 EFTA01493225